<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bittner, Dennis</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Winer, Eric P.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Impact of PST on Pathologic Response and Survival in Breast Cancer</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">21-22</style></pages><abstract><style  face="normal" font="default" size="100%">Considerable interest in preoperative systemic therapy (PST) for breast cancer has led to a large number of clinical trials investigating the potential of various preoperative treatments. A major driver in this effort has been the expectation that positive preoperative results would translate into improvements in disease-free survival and overall survival. This article discusses chemotherapy, the impact of PST to enable breast-conserving therapy, radiation issues after PST, as well as considerations for radiation therpay treatment of inflammatory breast cancer.</style></abstract><number><style face="normal" font="default" size="100%">31</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>